Contact Us


    Your Name (required)

    Your Email (required)

    Your Phone (required)

    Subject

    Interested In... (required)

    Your Message

    BioFlorida Conference For Early Stage Commercialization Strategies

    3PL Pharmaceutical conference
    Our Business Development Team

    A group from WDSrx attended the BioFlorida conference at InVentiv Health in Miami.  Keynote speaker Matthew Kim, Founder of Vigilant BioSciences discussed the stages leading to commercialization of the company’s oral cancer screening test.  Richard Erwin of Catalyst Pharmaceuticals joined a panel discussion about management issues involved in successful launches.  WDSrx supports BioFlorida as part of our strategy for meaningful involvement at every stage of the pharmaceutical 3PL supply chain.

    IMG_20160623_16412420160623_170728IMG_20160623_182939IMG_20160623_182353

    For further information contact WDSrx at info@wdsrx.com or (561) 998-3885.

    Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.